Nanosonics Limited

ASX:NAN ISIN:AU000000NAN9

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.

Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. 
 
   

View in Other Languages

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 13431

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Asian Markets Overview of March 30

🕔3/30/2009 3:00:25 PM 19696

Most Asian markets started the trading session with volatility on Monday after US stocks retreated on Friday. Tokyo and Seoul shares opened flat, and soon proceeded to a negative territory. Today Investors are also awaiting US government to unveil its plan to help the auto industry.

Read Full Article

Nanosonics Limited (ASX:NAN) Commences Production And Commercial First Sales of Trophon EPR

🕔3/30/2009 1:10:45 PM 6739

Nanosonics Limited (ASX:NAN) is pleased to announce that it has commenced production and commercial sale of its breakthrough Trophon(TM) EPR ultrasound probe disinfector system, through distribution partners in New Zealand and Australia.

Read Full Article
###

37,466 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 20) (Last 30 Days: 100) (Since Published: 9813) 

Company Data

    Headquarters
  • Unit 24, 566 Gardeners Road
    Alexandria NSW 2015
    Australia
  • Telephone
  • +61-2-8063-1600 
  • Fax
  • +61-2-9317-5010 
  • Principal Sector
  • Nanotechnology 
  • Principal Industry
  • Medical Products 
  • Homepage
  • http://www.nanosonics.com.au/

More News Results

  • 2025/08/26: 2025 Full Year Results Investor Presentation*
  • 2025/08/26: 2025 Full Year Financial Results*
  • 2025/08/26: 2025 Annual Report*
  • 2025/08/26: 2025 Sustainability Report*
  • 2025/08/26: Appendix 4G*
  • 2025/08/26: 2025 Corporate Governance Statement*
  • 2025/08/26: Appendix 4E*
  • 2025/08/07: FY25 Full Year Results webinar notification*
  • 2025/08/06: US FDA clearance received for next generation trophon*
  • 2025/07/25: Change in substantial holding*
*refer to company website